Free Trial

Solaris Resources (SLS) Competitors

Solaris Resources logo
C$13.25 +0.03 (+0.23%)
As of 04:00 PM Eastern

SLS vs. APHA, PBH, BHC, AUP, and CARA

Should you be buying Solaris Resources stock or one of its competitors? The main competitors of Solaris Resources include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Solaris Resources compare to Aphria?

Aphria (TSE:APHA) and Solaris Resources (TSE:SLS) are both mid-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Solaris Resources has lower revenue, but higher earnings than Aphria. Solaris Resources is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A

Solaris Resources' return on equity of 96.23% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Solaris Resources N/A 96.23%-51.67%

Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 47.17%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts plainly believe Solaris Resources is more favorable than Aphria.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Solaris Resources had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Aphria. Solaris Resources' average media sentiment score of 0.48 beat Aphria's score of 0.00 indicating that Solaris Resources is being referred to more favorably in the news media.

Company Overall Sentiment
Aphria Neutral
Solaris Resources Neutral

16.1% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Solaris Resources beats Aphria on 10 of the 13 factors compared between the two stocks.

How does Solaris Resources compare to Premium Brands?

Solaris Resources (TSE:SLS) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Premium Brands has higher revenue and earnings than Solaris Resources. Solaris Resources is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A
Premium BrandsC$7.48B0.58C$99.56MC$0.9092.12

Premium Brands has a net margin of 0.54% compared to Solaris Resources' net margin of 0.00%. Solaris Resources' return on equity of 96.23% beat Premium Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 96.23% -51.67%
Premium Brands 0.54%2.38%3.61%

In the previous week, Premium Brands had 5 more articles in the media than Solaris Resources. MarketBeat recorded 6 mentions for Premium Brands and 1 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.48 beat Premium Brands' score of 0.39 indicating that Solaris Resources is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Premium Brands
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

16.1% of Solaris Resources shares are owned by institutional investors. Comparatively, 33.0% of Premium Brands shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 2.0% of Premium Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Solaris Resources has a beta of 1.845161, suggesting that its share price is 85% more volatile than the S&P 500. Comparatively, Premium Brands has a beta of 0.860077, suggesting that its share price is 14% less volatile than the S&P 500.

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 47.17%. Premium Brands has a consensus target price of C$116.36, suggesting a potential upside of 40.35%. Given Solaris Resources' higher possible upside, research analysts plainly believe Solaris Resources is more favorable than Premium Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Premium Brands
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

Premium Brands beats Solaris Resources on 10 of the 15 factors compared between the two stocks.

How does Solaris Resources compare to Bausch Health Companies?

Solaris Resources (TSE:SLS) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 96.23% -51.67%
Bausch Health Companies -13.54%120.43%4.16%

In the previous week, Bausch Health Companies had 3 more articles in the media than Solaris Resources. MarketBeat recorded 4 mentions for Bausch Health Companies and 1 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.48 beat Bausch Health Companies' score of 0.22 indicating that Solaris Resources is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 47.17%. Given Solaris Resources' stronger consensus rating and higher possible upside, research analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Solaris Resources has higher earnings, but lower revenue than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A

16.1% of Solaris Resources shares are owned by institutional investors. Comparatively, 13.5% of Bausch Health Companies shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Solaris Resources has a beta of 1.845161, suggesting that its share price is 85% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.588188, suggesting that its share price is 41% less volatile than the S&P 500.

Summary

Solaris Resources beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Solaris Resources compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Solaris Resources (TSE:SLS) are both mid-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Solaris Resources' return on equity of 96.23% beat Aurinia Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurinia PharmaceuticalsN/A N/A N/A
Solaris Resources N/A 96.23%-51.67%

In the previous week, Solaris Resources had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Aurinia Pharmaceuticals. Solaris Resources' average media sentiment score of 0.48 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Solaris Resources is being referred to more favorably in the news media.

Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Solaris Resources Neutral

Solaris Resources has a consensus target price of C$19.50, indicating a potential upside of 47.17%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Solaris Resources has lower revenue, but higher earnings than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A

16.1% of Solaris Resources shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 10 of the 13 factors compared between the two stocks.

How does Solaris Resources compare to Cara Operations?

Solaris Resources (TSE:SLS) and Cara Operations (TSE:CARA) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Solaris Resources currently has a consensus target price of C$19.50, indicating a potential upside of 47.17%. Given Solaris Resources' stronger consensus rating and higher probable upside, research analysts plainly believe Solaris Resources is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

16.1% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Solaris Resources' return on equity of 96.23% beat Cara Operations' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 96.23% -51.67%
Cara Operations N/A N/A N/A

In the previous week, Solaris Resources had 1 more articles in the media than Cara Operations. MarketBeat recorded 1 mentions for Solaris Resources and 0 mentions for Cara Operations. Solaris Resources' average media sentiment score of 0.48 beat Cara Operations' score of 0.00 indicating that Solaris Resources is being referred to more favorably in the media.

Company Overall Sentiment
Solaris Resources Neutral
Cara Operations Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.26N/A
Cara OperationsN/AN/AN/AN/AN/A

Summary

Solaris Resources beats Cara Operations on 8 of the 9 factors compared between the two stocks.

Get Solaris Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLS vs. The Competition

MetricSolaris ResourcesOther Precious Metals & Mining IndustryMaterials SectorTSE Exchange
Market CapC$2.21BC$653.35MC$4.72BC$11.72B
Dividend YieldN/A6.03%4.98%6.22%
P/E Ratio-50.9612.3420.9723.83
Price / SalesN/A3,619.857,339.1413.46
Price / Cash64.5313.0424.3582.69
Price / Book-45.2313.617.704.48
Net Income-C$46.49M-C$4.87MC$159.29MC$300.68M
7 Day Performance-4.26%-2.03%0.01%0.12%
1 Month Performance7.99%-0.03%2.58%2.88%
1 Year Performance124.20%102.76%76.05%57.78%

Solaris Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLS
Solaris Resources
1.6716 of 5 stars
C$13.25
+0.2%
C$19.50
+47.2%
N/AC$2.21BN/AN/A10
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
PBH
Premium Brands
3.434 of 5 stars
C$84.76
+1.6%
C$116.36
+37.3%
N/AC$4.41BC$7.48B94.18540
BHC
Bausch Health Companies
0.5813 of 5 stars
C$8.44
+10.2%
N/AN/AC$3.15BC$10.27B20.1019,900
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59MN/A300

Related Companies and Tools


This page (TSE:SLS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners